Xiaomeng C. Song
Nanjing, 210006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Analysis of risk factors for acute kidney injury following reoperative cardiac surgery
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: May 27, 2026
Targeting lipoprotein lipase-positive macrophage-driven GDF-15 expression alleviates cancer Cachexia in obese head and neck squamous cell carcinoma.
Journal: Cellular signalling
Published: January 28, 2026
CBCT-based virtual surgical planning for predicting risk factors and preventive strategies of buccal plate perforation in maxillary premolar implant placement.
Journal: Head & face medicine
Published: November 28, 2025
NDUFA4L2 regulates the progression and chemotherapy sensitivity of HNSCC by inhibiting PANoptosis.
Journal: NPJ precision oncology
Published: November 12, 2025
Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Journal: Cell death & disease
Published: December 16, 2024
TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation.
Journal: Cell communication and signaling : CCS
Published: August 24, 2024
FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.
Journal: Cancer research
Published: July 23, 2024
NUTF2 Promotes Proliferation of Oral Squamous Cell Carcinoma Through PI3K/AKT Signaling Pathway.
Journal: Oral diseases
Published: May 24, 2024
Erratum: Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum.
Journal: International journal of biological sciences
Published: March 14, 2024
E3 ubiquitin ligase TRIM31 alleviates dopaminergic neurodegeneration by promoting proteasomal degradation of VDAC1 in Parkinson's Disease model.
Journal: Cell death and differentiation
Published: July 11, 2023
Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway.
Journal: American journal of cancer research
Published: April 20, 2023
MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1.
Journal: Cellular signalling
Published: March 29, 2023
Last Updated: 09/26/2026